Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis.

Koumakis E, Bouaziz M, Dieudé P, Cauvet A, Ruiz B, Airò P, Cusi D, Matucci-Cerinic M, Salvi E, Cuomo G, Hachulla E, Diot E, Caramaschi P, Riccieri V, Avouac J, Allanore Y.

Clin Exp Rheumatol. 2016 Jul 1. [Epub ahead of print]

PMID:
27385538
2.

Varicella-Zoster virus hip arthritis in a rheumatoid arthritis patient.

Senlis M, Ottaviani S, Gardette A, Palazzo E, Coustet B, Dieudé P.

Joint Bone Spine. 2016 Jun 3. pii: S1297-319X(16)30063-X. doi: 10.1016/j.jbspin.2016.02.030. [Epub ahead of print] No abstract available.

PMID:
27269653
3.

Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: Prevalence and associated phenotype.

Maillet J, Ottaviani S, Tubach F, Roy C, Nicaise-Rolland P, Palazzo E, Dieudé P.

Joint Bone Spine. 2016 Mar 15. pii: S1297-319X(16)00037-3. doi: 10.1016/j.jbspin.2015.10.011. [Epub ahead of print]

PMID:
26992953
4.

Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.

Gardette A, Ottaviani S, Sellam J, Berenbaum F, Lioté F, Meyer A, Sibilia J, Fautrel B, Palazzo E, Dieudé P.

Clin Rheumatol. 2016 Apr;35(4):857-61. doi: 10.1007/s10067-016-3183-3. Epub 2016 Jan 22.

PMID:
26801332
5.

Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort.

Vandhuick T, Allanore Y, Borderie D, Louvel JP, Fardellone P, Dieudé P, Goëb V, Clavel G, Boissier MC, Jouen F, Boumier P, Allart JD, Mejjad O, Pouplin S, Jan M, Ménard JF, Le Loët X, Vittecoq O.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):58-67. Epub 2015 Dec 20.

PMID:
26744355
6.

A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort).

Ruyssen-Witrand A, van Steenbergen HW, van Heemst J, Gourraud PA, Nigon D, Lukas C, Miceli-Richard C, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, van der Helm-van Mil AH, Constantin A.

RMD Open. 2015 Nov 19;1(1):e000099. doi: 10.1136/rmdopen-2015-000099. eCollection 2015.

7.

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Dieudé P, Pers JO, Cornec D, Seror R, Mariette X, Nowak E, Saraux A.

PLoS One. 2015 Sep 14;10(9):e0133907. doi: 10.1371/journal.pone.0133907. eCollection 2015.

8.

Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.

Ochoa E, Martin JE, Assasi S, Beretta L, Carreira P, Guillén A, Simeón CP, Koumakis E, Dieude P, Allanore Y, García-Hernández FJ, Espinosa G, Castellví I, Trapiella JL, Rodriguez L, González-Gay MÁ, Egurbide MV, Sáez L, Callejas-Rubio JL, Vargas-Hitos JA, Hunzelmann N, Riemekasten G, Witte T, Distler JH, Kreuter A, Lunardi C, Santaniello A, Tan FK, Shiels PG, Herrick A, Worthington J, Vonk MC, Koeleman BP, Radstake TR, Mayes MD, Martin J; Spanish Scleroderma Group.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S31-5. Epub 2015 Aug 27.

PMID:
26314374
9.

Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.

Nocturne G, Pavy S, Boudaoud S, Seror R, Goupille P, Chanson P, van der Heijde D, van Gaalen F, Berenbaum F, Mariette X, Briot K, Feydy A, Claudepierre P, Dieudé P, Nithitham J, Taylor KE, Criswell LA, Dougados M, Roux C, Miceli-Richard C.

PLoS One. 2015 Aug 27;10(8):e0134974. doi: 10.1371/journal.pone.0134974. eCollection 2015.

10.

Body Mass Index and response to rituximab in rheumatoid arthritis.

Ottaviani S, Gardette A, Roy C, Tubach F, Gill G, Palazzo E, Meyer O, Dieudé P.

Joint Bone Spine. 2015 Dec;82(6):432-6. doi: 10.1016/j.jbspin.2015.02.011. Epub 2015 Jul 14.

PMID:
26184536
11.

Sensitivity and Reproducibility of Ultrasonography in Calcium Pyrophosphate Crystal Deposition in Knee Cartilage: A Cross-sectional Study.

Ottaviani S, Juge PA, Aubrun A, Palazzo E, Dieudé P.

J Rheumatol. 2015 Aug;42(8):1511-3. doi: 10.3899/jrheum.141067. Epub 2015 Jun 15.

PMID:
26077407
12.

Tuberculous cervical lymphadenitis in a gouty patient treated with anakinra.

Ottaviani S, Dieudé P.

J Clin Rheumatol. 2015 Jun;21(4):230. doi: 10.1097/RHU.0000000000000254. No abstract available.

PMID:
26010193
13.

A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis.

Marangoni RG, Korman BD, Allanore Y, Dieude P, Armstrong LL, Rzhetskaya M, Hinchcliff M, Carns M, Podlusky S, Shah SJ, Ruiz B, Hachulla E, Tiev K, Cracowski JL, Varga J, Hayes MG.

Arthritis Res Ther. 2015 May 19;17:128. doi: 10.1186/s13075-015-0641-2.

14.

Tocilizumab for refractory organising pneumonia associated with Sjögren's disease.

Justet A, Ottaviani S, Dieudé P, Taillé C.

BMJ Case Rep. 2015 May 14;2015. pii: bcr2014209076. doi: 10.1136/bcr-2014-209076.

PMID:
25976199
15.

Body mass index and response to infliximab in rheumatoid arthritis.

Ottaviani S, Gardette A, Tubach F, Roy C, Palazzo E, Gill G, Meyer O, Dieudé P.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):478-83. Epub 2015 May 11.

PMID:
25962513
16.

Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.

Arismendi M, Giraud M, Ruzehaji N, Dieudé P, Koumakis E, Ruiz B, Airo P, Cusi D, Matucci-Cerinic M, Salvi E, Cuomo G, Hachulla E, Diot E, Caramaschi P, Riccieri V, Avouac J, Kayser C, Allanore Y.

Arthritis Res Ther. 2015 Mar 21;17:71. doi: 10.1186/s13075-015-0572-y.

17.

Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression.

Miceli-Richard C, Taylor KE, Nititham J, Seror R, Nocturne G, Boudaoud S, Dieude P, Constantin A, Devauchelle-Pensec V, Tobón GJ, Mariette X, Criswell LA.

Ann Rheum Dis. 2015 Jul;74(7):1480-1. doi: 10.1136/annrheumdis-2014-206530. Epub 2015 Mar 24. No abstract available.

PMID:
25805736
18.

Ultrasound in gout: a useful tool for following urate-lowering therapy.

Ottaviani S, Gill G, Aubrun A, Palazzo E, Meyer O, Dieudé P.

Joint Bone Spine. 2015 Jan;82(1):42-4. doi: 10.1016/j.jbspin.2014.03.011. Epub 2014 Dec 24.

PMID:
25543275
19.

High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis.

Gardette A, Ottaviani S, Tubach F, Roy C, Nicaise-Roland P, Palazzo E, Gill G, Meyer O, Dieudé P.

Joint Bone Spine. 2014 Oct;81(5):416-20. doi: 10.1016/j.jbspin.2014.06.001. Epub 2014 Jul 3.

PMID:
24998790
20.

SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis.

Juge PA, van Steenbergen HW, Constantin A, Tobon GJ, Schaeverbeke T, Gazal S, Combe B, Devauchelle-Pensec V, Nigon D, van der Helm-van Mil AH, Dieude P.

Ann Rheum Dis. 2014 Oct;73(10):1840-3. doi: 10.1136/annrheumdis-2014-205539. Epub 2014 Jun 16.

PMID:
24936586
Items per page

Supplemental Content

Loading ...
Write to the Help Desk